CVS Health
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 week.
- Recent price momentum is +2.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is above its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Anonymous reader poll. Unscientific, not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 92.58
- Open
- 93.24
- Day range
- 92.05 - 93.35
- Avg price
- 92.60
- Volume
- 6.98M
- Turnover
- 646.48M
- Turnover ratei
- 0.55%
- Volume ratioi
- 0.61
- Amplitudei
- 1.40%
- 52-week rangei
- 68.48 - 110.00
Valuation
- P/Ei
- 66.45
- P/E (TTM)i
- 24.37
- P/Bi
- 1.48
- EPSi
- 1.39
- Book value / shi
- 62.32
- Net profit
- 1.78B
- Net assets
- 79.70B
Share structure
- Market cap
- 118.13B
- Float capi
- 117.89B
- Shares out
- 1.28B
- Float sharesi
- 1.28B
Dividend & listing
- Div yield (TTM)i
- 2.88%
- Dividend (TTM)
- 2.66
- Listing date
- 1970-01-01
16.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-265.39M net over the window
Short interest
- Shares short
- 16.47M
- % of floati
- 1.29%
- Days to coveri
- 1.66
- As of
- 2026-09-30
Frequently asked questions
What is the current stock price of CVS Health (CVS)?
CVS Health last traded at 92.36. The quote on this page refreshes every few seconds while US markets are open.
What is CVS Health's market cap?
About 118.13B.
What is the P/E ratio of CVS Health?
The trailing twelve-month P/E is 24.37, below its own 5-year average of 32.25 — in the middle of its historical range (63.21% percentile). See the Valuation tab for the full history.
Does CVS Health pay a dividend?
Yes. The trailing dividend yield is 2.88%. The 2025 payout was little changed from 2024. See the Dividends tab for the full payment history.
Is CVS Health a buy according to analysts?
The consensus of 17 analysts is a Buy rating, with an average 12-month price target of 115.06, which implies 24.6% upside from the current price. This is not investment advice.
What is CVS Health's StockVane Quant Rating?
The StockVane Momentum strategy currently rates CVS Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-16 20:02:34 · For reference only, not investment advice and not tailored to your situation.
CVS Health discussion 0 comments